Keith Regnante Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Regnante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Regnante. Keith Regnante is Chief Financial Officer in Wave Life Sciences Ltd. ($WVE) and Chief Financial Officer in Keros Therapeutics, Inc. ($KROS).
Latest Insider Trading Transactions of Keith Regnante
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 70.93 | 49,150 | 3,486,210 | 49,150 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 133,622 | 2,137,952 | 133,622 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 18,430 | 294,880 | 18,430 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 133,622 | 2,137,952 | 133,622 | |
| Apr 08 2020 | KROS | Keros Therapeutics ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 16.00 | 18,430 | 294,880 | 18,430 | |
| Mar 11 2019 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Grant | A | 0.00 | 13,500 | 0 | 29,186 | 15.7 K to 29.2 K (+86.06 %) |
| Feb 21 2019 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Sell | S | 36.84 | 1,298 | 47,818 | 15,686 | 17 K to 15.7 K (-7.64 %) |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Option Exercise | M | 20.89 | 29,500 | 616,255 | 90,500 | |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Sell | S | 55.00 | 29,500 | 1,622,500 | 16,984 | 46.5 K to 17 K (-63.46 %) |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Buy | M | 20.89 | 29,500 | 616,255 | 46,484 | 17 K to 46.5 K (+173.69 %) |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Option Exercise | M | 20.89 | 29,500 | 616,255 | 90,500 | |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Sell | S | 55.00 | 29,500 | 1,622,500 | 16,984 | 46.5 K to 17 K (-63.46 %) |
| Sep 26 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Buy | M | 20.89 | 29,500 | 616,255 | 46,484 | 17 K to 46.5 K (+173.69 %) |
| Feb 21 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Sell | S | 51.85 | 316 | 16,385 | 16,984 | 17.3 K to 17 K (-1.83 %) |
| Jan 25 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 40.05 | 26,000 | 1,041,300 | 26,000 | |
| Jan 25 2018 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Grant | A | 0.00 | 13,000 | 0 | 17,300 | 4.3 K to 17.3 K (+302.33 %) |
| Jan 27 2017 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 29.05 | 8,600 | 249,830 | 8,600 | |
| Jan 27 2017 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Grant | A | 0.00 | 4,300 | 0 | 4,300 | 0 to 4.3 K |
| Aug 17 2016 | WVE | Wave Life Sciences ... | Regnante Keith | Chief Financial Off ... | Option Exercise | A | 20.89 | 120,000 | 2,506,800 | 120,000 |
Page: 1